Antisense Therapeutics Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Antisense Therapeutics Limited with three other
companies in this sector in AUSTRALIA :
Amplia Therapeutics Ltd
(2020
sales of 34,227.00 Australian Dollars [US$26,369.17 ]
),
Race Oncology Ltd
(9,316.00 Australian Dollars [US$7,177.23 ]
), and
Vectus Biosystems Ltd
(51,186.00 Australian Dollars [US$39,434.72 ]
).
Sales Analysis.
Sales levels dropped significantly in the second
fiscal
quarter of 2021 versus the previous year's second quarter.
During the second
fiscal
quarter of 2021, sales at Antisense Therapeutics Limited totalled
A$2,185.00 .
This is a drop of 92.1%
from the A$27,494.00 in sales at the company during the second quarter in 2020.
Antisense Therapeutics Limited reported sales of A$30,528.00 (US$23.52 thousand)
for the
fiscal
year ending
June of 2020.
This
represents
a
sharp
decrease of 53.9%
versus 2019, when the company's sales were A$66,168.00 .